Skip to main content
SpringerLink
Log in

Positiv-inotrope Substanzen in der Kardiologie

  • Chapter
Herzkrankheiten

  • 242 Accesses

Zusammenfassung

Die Reduktion der Vor- und Nachlast bei myokardialer Dysfunktion durch ACE-Inhibitoren, AT1Rezeptor-lnhibitoren und Vasodilatatoren, evtl. ergänzt durch Diuretika, bessert v.a. indirekt die Förderleistung des Herzens. In Abhängigkeit vom Schweregrad der myokardialen Schädigung kann es zusätzlich erforderlich sein, direkt die Inotropie des Herzmuskels zu steigern. Dabei muss unterschieden werden zwischen der Notwendigkeit einer evtl. Akutintervention sowie einer möglichen Langzeittherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amin DK, Shah PK, Hülse S et al (1984) Myocardial metabolit and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure. Am Heart J 108:1285

    Article  PubMed  CAS  Google Scholar 

  • Applefeld MM, Newman KA, Grove WR et al (1983) Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. Am J Cardiol 51:455

    Article  PubMed  CAS  Google Scholar 

  • Bairn DS, McDwell AV, Cherniles J et al (1983) Evaluation of a new bipyridine inotropic agent — milrinone — in patients with severe congestive heart failure. New Engl Med 309:748

    Article  Google Scholar 

  • Benotti Jr, Grossman W, Braunwald E et al (1978) Hemodynamic assessment of amiodarone. A new inotropic agent. N Engl J Med 299:1373

    Article  PubMed  CAS  Google Scholar 

  • Bloom PhM, Nelp WB (1966) Relationship of the excretion of tritiated digoxin to renal function. Am J med Sci 251:43

    Article  Google Scholar 

  • Cohn JN, Goldstein SO, Greenberg BH et al (1998) A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med 339:1810

    Article  PubMed  CAS  Google Scholar 

  • Cyran J, Bolte HD (1979) Kombinierte Infusion von Nitroprussid-Natrium und Dobutamin zur Behandlung der hochgradigen Linksherzinsuffizienz bei koronarer Herzkrankheit. Klin Wochenschr 57:883

    Article  PubMed  CAS  Google Scholar 

  • Cyran J, Kühnl Ch, Zähringer J et al (1978) Die Änderung der Hämodynamik des Herzens unter dem kombinierten Einfluß von Nitroglycerin und Dopamin bei hochgradiger Linksherzinsuffizienz. Z Kardiol 67:759

    PubMed  CAS  Google Scholar 

  • Delius W, Wirtzfeld A, Sebening H, Mathes P (1976) Hämodynamische Wirkung von Dobutamin bei Patienten mit Herzinsuffizienz. Dtsch med Wschr 101:1747

    Article  PubMed  CAS  Google Scholar 

  • Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525

    Article  Google Scholar 

  • Erdmann E, Brown L, Lorenz B et al (1985a) Altersabhängige Regulation der Herzglykosidrezeptoren. Z Kardiol 74(Suppl 7):33

    PubMed  Google Scholar 

  • Erdmann E, Werdan K, Brown L (1985b) Multiplicity of cardiac glycoside receptor in the heart. Trends Pharmacol Sci 6:293

    Article  CAS  Google Scholar 

  • Ferguson DW (1990) Baroreflex-mediated circulatory control in human heart failure. Heart Failure 6:3

    Google Scholar 

  • Figgitt DP, Gillies PS, Goa KL (2001) Levosimendan. Drugs 61:613

    Article  PubMed  CAS  Google Scholar 

  • Follath F, Cleland JGF, Just H et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO-study): a randomised double-blind trial. Lancet 360:196

    Article  PubMed  CAS  Google Scholar 

  • Goldberg LI, Rajfer SI (1985) Dopamine receptors: applications in clinical cardiology: Circulation 72:245

    PubMed  CAS  Google Scholar 

  • Grosse-Brockhoff F, Hengels KJ, Fritsch WP et al (1973) Serumdigoxinspiegel und Nierenfunktion. Dtsch med Wochenschr 98:1547

    Article  PubMed  CAS  Google Scholar 

  • Hauf GF, Bubenheimer P, Roskamm H (1981) The acute effect of a new positive inotropic agent (AR-L115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure. Arzneim Forsch 31(la):253

    CAS  Google Scholar 

  • Karlsberg RP, DeWood MA, DeMaria AN, Berk MR, Lasher KP for the Milrinone-Dobutamine Study Group (1996) Comparative efficacy of short-term interavenous infusiaon of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Clin Cardiol 19:21

    Google Scholar 

  • Kereiakes DJ, Viquerat C, Lanzer P et al (1984) Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.Am Heart J 108:1278

    Article  PubMed  CAS  Google Scholar 

  • Klein G, Sauer E, Bauer R, Wirtzfeld A, Sebening H (1981) The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure. Arzneim Forsch 31(l,la):257

    CAS  Google Scholar 

  • König K, Reindell H, Hoffmann G, Achtermann R (1964) Zur Frage der Glykosid-Therapie bei der latenten Herzinsuffizienz (Belastungsinsuffizienz) unter besonderer Berücksichtigung des Altersherzens. Arch Kreisl Forsch 43:86

    Article  Google Scholar 

  • Kubo SH, Cody RJ, Chatterjee K et al (1985) Acute dose range study of milrinone in congestive heart failure. Am J Cardiol 55:726

    Article  PubMed  CAS  Google Scholar 

  • Kubo SH, Gollub S, Bourge R et al (1992) Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. Circulation 85:942

    Article  PubMed  CAS  Google Scholar 

  • Leier CV, Huss P, Lewis RP, Unverferth DV (1982) Drug-induced conditioning in congestive heart failure. Circulation 65:1382

    Article  PubMed  CAS  Google Scholar 

  • Liang CS, Sherman LG, Doherty JU et al (1984) Sustained improvement of cardiac function in patients with congestive heart failure after shortterm infusion of dobutamine. Circulation 69:113

    Article  PubMed  CAS  Google Scholar 

  • Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH (1990) Therapie des kardiogenen Schocks und der schwersten Herzinsuffizienz mit dem Phosphodiesterasehemmer Milrinon. Intensivmed 27:238

    Google Scholar 

  • Mason DT, Spann Jr JF, Zelis R (1969) New developments in the understanding of the actions of the digitalis glycosides. Progr cardiovasc Dis 11:443

    Article  CAS  Google Scholar 

  • Murphy MB, Murray C, Shorten GD (2001) Fenoldopam — a selective peripheral dopamine receptor agonist for the treatment of severe hypertension. N Eng J Med 346:1548

    Google Scholar 

  • Ooi H, Colucci WS (2001) Pharmacological treatment of heart failure. In: Gooman and Gilman’s The pharmacological basis of therapeutics, 10th ed. McGraw-Hill New York, p 901

    Google Scholar 

  • Packer M, Medina N, Yushak M (1984) Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation 70:1038

    Article  PubMed  CAS  Google Scholar 

  • Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347:1403

    Article  PubMed  CAS  Google Scholar 

  • Rüegg J C (1986) Effects of new inotropic agents on Ca++ sensitivity of contractile proteins. Circulation 73(Suppl lll):78

    Google Scholar 

  • Scholz H, Meyer W (1986) Phosphodiesterase-inhibiting properties of newer inotropic agents. Circulation 73(Suppl lll):99

    Google Scholar 

  • Shah PK, Amin DK, Hulse S et al (1985) Inotropic therapy for refractory congestive heart failure with oral enoximone (MDL-17,043); poor long-term results despite early hemodynamic and clinical improvement. Circulation 71:326

    Article  PubMed  CAS  Google Scholar 

  • Simoons ML, Muskens G, Hugenholtz PG (1983) Hemody namic effects of salmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock. Herz 8:34

    PubMed  CAS  Google Scholar 

  • Skou JC (1957) The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochem Biophys Acta 23:349

    Article  Google Scholar 

  • Solaro RJ, Rüegg JC (1982) Stimulation of Ca++ binding and ATPase activity of dog cardiac myofibrils by AR-L 115 BS, a novel cardiotonic agent. Circulat Res 51:290

    Article  PubMed  CAS  Google Scholar 

  • Sonnenblick EH, Frishman WH, LeJemtel TH (1979) Dobutamine: A new synthetic cardioactive sympathetic amine. New Engl J Med 300:17

    Article  PubMed  CAS  Google Scholar 

  • Storstein O, Hansteen V, Hatle L et al (1977) Studies on digitalis XIII. A prospective study of 649 patients on maintenance treatment with digitoxin. Am Heart J 93:434

    Article  PubMed  CAS  Google Scholar 

  • Toda N, West CT (1969) The action of ouabain on cholinergic responses in the sinoatrial mode. J Pharmacol Exp Ther 153:774

    Google Scholar 

  • Tuttle RR (1978) ß-selectivity of dobutamine and its potential für cardiovascular therapy. In: Just H (Hrsg) Dobutamin. Springer, Berlin Heidelberg New York, S 61

    Chapter  Google Scholar 

  • Tuttle RR, Mills J (1975) Dobutamine. Development of a new catecholamine to selectively increase cardiac contractility. Circulat Res 36:185

    Article  PubMed  CAS  Google Scholar 

  • Uretsky BF, Jessup M, Konstam MA et al (1990) Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Circulation 82:774

    Article  PubMed  CAS  Google Scholar 

  • Werdan K, Erdmann E (1988) Glykosidrezeptoren des Herzens. Fortschr Med 106:135

    PubMed  CAS  Google Scholar 

  • Wirtzfeld A, Klein G, Delius W et al (1978) Dopamin und Dobutamin in der Behandlung der schweren Herzinsuffizienz. Dtsch med Wschr 103:1915

    Article  PubMed  CAS  Google Scholar 

  • Withering W (1937) An account of the foxglove and some of its medical uses: With practical remarks on dropsy and other diseases. C.G.J.&J. Robinson, London 1785, reprinted in Med Class 2:305

    Google Scholar 

  • Yasunari K, Kohno M, Kano H et al (2000) Dopamine as a novel antooxidative agent for rat vascular smooth muscle cells through dopamine D1-like receptors. Circulation 101:2302

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. F. Hauf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Grom
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Herz-Zentrum Bad Krozingen, Südring 15, 79188, Bad Krozingen, Germany

    H. Roskamm , F.-J. Neumann , D. Kalusche  & H.-P. Bestehorn , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hauf, G.F., Grom, E. (2004). Positiv-inotrope Substanzen in der Kardiologie. In: Roskamm, H., Neumann, FJ., Kalusche, D., Bestehorn, HP. (eds) Herzkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18649-3_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18649-3_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62220-5

  • Online ISBN: 978-3-642-18649-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation